[1] KAMAR N,MARION O,ABRAVANEL F,et al.Extrhepatic manifestations of hepatitis E virus[J]. Liver Int,2016,36(4):467-472. [2] 刘丽. 33例老年戊型肝炎患者临床与血清学特征分析[J]. 肝脏,2017,22(9):816-818. [3] DALTON H R,KAMAR N,IZOPET J.Hepatitis E in developed countries:current status and future perspectives[J].Future Microbiol,2014,9(12):1361-1372. [4] 鲁真真,童书青,栾芳,等. 老年戊型肝炎患者肝功能分析[J]. 临床输血与检验,2017,19(1):67-70. [5] 考庆君,孙昼,谢立,等.杭州市2004—2011年戊型肝炎流行特征及病原学分析[J].中华预防医学杂志,2014,48(9):766-770. [6] BRADLEY-STEWART A J,JESUDASON N,MICHIE K,et al.Hepatitis E in Scotland:assessment of HEV infection in two high-risk patient groups with elevated liver enzymes[J].J Clin Virol,2015,63:36-37. [7] 史冬梅,王晓琳,项晓刚,等. 236例急性戊型肝炎的临床特征及危险因素分析[J]. 肝脏,2017,22(6):498-501. [8] European Association for the Study of the Liver. EASL clinical practice guidelines on hepatitis E virus infection[J]. J Hepatol,2018 68(6):1256-1271. [9] 丁永华,范桂玲. 分子吸附再循环系统治疗老年重型戊型肝炎31例[J]. 中国老年学杂志,2013,33(3):650-651. [10] MORI N,SUZUKI F,KAWAMURA Y,et al.Determinants of the chinical outcome of patients with severe acute exacerbation of chronic hepatitis B virus infection[J].J Gastroenterol,2012,47(9):1022-1029. [11] 刘洁,白浪,陈立宇,等.老年戊型肝炎36例临床分析[J].西部医学,2008,20(2):313-314. [12] ZHANG J,LI S W,WU T,et al.Hepatitis E virus:neutralizing sites,diagnosis,and protective immunity[J].Rev Med Virol,2012,22(5):339-349. [13] 李春杨,戴明佳,汪莉萍,等. 老年病毒性肝炎临床特点及防治措施[J]. 中国老年学杂志,2018,38(1):380-382. |